Pharmaco(Epi)Genetic Study of Obsessive-Compulsive Disorder

• Status: Recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether pharmaco(epi)genetic study predict selective serotonin reuptake inhibitor (SSRI) responsiveness in advance before the appearance of the drug effect until 4 months(16 weeks), 6 months, and 1 year after administration of SSRIs.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Severance Hospital
• Treatments: Fluoxetine

Criteria

Inclusion Criteria:

1. age 19~ 70

2. OCD by Diagnostic and Statistical Manual for Mental disorders, 4th edition (DSM-IV)

3. drug naive or drug free for more than 3 months

Exclusion Criteria:

1. any neurological disorder

2. comorbid psychotic disorders

3. alcohol or other substance dependence within past 6 months

4. any evidences for brain diseases